Fundamental analysts appear to be positive about a number of Merck & Co.'s (MRK) cancer treatments and that seems to be translating into a strong looking charts and indicators. Let's check.
More from Investing
Medtronic Could Touch a New Low as It Bottoms
Let's see what the the charts and indicators look like.
Marathon Petroleum Is Ready for a Run: Here's How to Play It
The shares are in an upward trend, but it's more complicated than that.
Here's How I'm Approaching the Popular TLT Treasury Bond ETF
The thing is, this ETF could break either way based on where it is at present.
Alibaba Shares Skyrocket in Hong Kong on Restructuring Plan
The company will split into six separate entities which will be run under separate management and free to list independently.
I Wouldn't Plow Ahead With Buying Deere Despite an Analyst's Thumbs Up
The technical picture of the farm equipment giant simply isn't encouraging.